Category: Corporate

Triple Hair Expands Global Phase III Program for TH07 with Launch of 500-Patient Trial in India corporate Triple Hair Group Inc. (“Triple Hair” or the “Company”), a company specializing in the development of innovative treatments for androgenic alopecia (pattern baldness), today announced the initiation of its Phase III clinical trial in India evaluating TH07, the … Continued

Triple Hair Doses First Patient in Phase III Clinical Trial in Canada for Male Androgenic Alopecia Corporate Triple Hair Group Inc. (“Triple Hair” or the “Company”), a company specializing in the development of innovative treatments for androgenic alopecia (pattern baldness), today announced that the first patient has been dosed in its Phase III clinical trial … Continued

Triple Hair Group Signs Licensing Agreement for the Brazilian Market with Aché Triple Hair Group Inc. (“Triple Hair” or the “Company”), a company specializing in the development of innovative treatments for androgenic alopecia, is pleased to announce that it has signed a licensing agreement with Aché Laboratorios Farmacêuticos S.A. (“Aché”), granting Aché exclusive rights to … Continued

Triple Hair Group Strengthens Leadership Team with Appointment of Paul Sowyrda to its Board of Directors Triple Hair Group Inc. (“Triple Hair” or the “Company”), a company specializing in the development of innovative treatments for androgenic alopecia, is pleased to announce the appointment of Paul Sowyrda to its Board of Directors. Paul Sowyrda is an … Continued

Triple Hair Group Enters Into Licensing Agreement with Akums for Therapy-07 in India Corporate Triple Hair Group Inc. (“Triple Hair” or the “Company”), a company specializing in the development of innovative treatments for androgenic alopecia, is pleased to announce that it has entered into a strategic partnership with Akums Drugs & Pharmaceuticals Ltd. (“Akums”), India’s … Continued

Triple Hair Group Receives EMA Approval to Start Phase III Clinical Trials on its Therapy-07 Prescription Drug in Europe Corporate Triple Hair Group Inc. (“Triple Hair” or the “Company”), a company specializing in the development of innovative treatments for androgenic alopecia, is pleased to announce that it has received approval from the European Medicines Agency … Continued